SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:0964 6906 "

Sökning: L773:0964 6906

  • Resultat 21-30 av 458
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
21.
  •  
22.
  • Aspatwar, Ashok, et al. (författare)
  • Abnormal cerebellar development and ataxia in CARP VIII morphant zebrafish
  • 2013
  • Ingår i: Human Molecular Genetics. - : Oxford University Press (OUP). - 0964-6906 .- 1460-2083. ; 22:3, s. 417-432
  • Tidskriftsartikel (refereegranskat)abstract
    • Congenital ataxia and mental retardation are mainly caused by variations in the genes that affect brain development. Recent reports have shown that mutations in the CA8 gene are associated with mental retardation and ataxia in humans and ataxia in mice. The gene product, carbonic anhydrase-related protein VIII (CARP VIII), is predominantly present in cerebellar Purkinje cells, where it interacts with the inositol 1,4,5-trisphosphate receptor type 1, a calcium channel. In this study, we investigated the effects of the loss of function of CARP VIII during embryonic development in zebrafish using antisense morpholino oligonucleotides against the CA8 gene. Knockdown of CA8 in zebrafish larvae resulted in a curved body axis, pericardial edema and abnormal movement patterns. Histologic examination revealed gross morphologic defects in the cerebellar region and in the muscle. Electron microscopy studies showed increased neuronal cell death in developing larvae injected with CA8 antisense morpholinos. These data suggest a pivotal role for CARP VIII during embryonic development. Furthermore, suppression of CA8 expression leads to defects in motor and coordination functions, mimicking the ataxic human phenotype. This work reveals an evolutionarily conserved function of CARP VIII in brain development and introduces a novel zebrafish model in which to investigate the mechanisms of CARP VIII-related ataxia and mental retardation in humans.
  •  
23.
  •  
24.
  • Atanassova, N, et al. (författare)
  • Sequence-specific stalling of DNA polymerase gamma and the effects of mutations causing progressive ophthalmoplegia
  • 2011
  • Ingår i: Human Molecular Genetics. - 0964-6906. ; 20:6, s. 1212-1223
  • Tidskriftsartikel (refereegranskat)abstract
    • A large number of mutations in the gene encoding the catalytic subunit of mitochondrial DNA polymerase γ (POLγA) cause human disease. The Y955C mutation is common and leads to a dominant disease with progressive external ophthalmoplegia and other symptoms. The biochemical effect of the Y955C mutation has been extensively studied and it has been reported to lower enzyme processivity due to decreased capacity to utilize dNTPs. However, it is unclear why this biochemical defect leads to a dominant disease. Consistent with previous reports, we show here that the POLγA:Y955C enzyme only synthesizes short DNA products at dNTP concentrations that are sufficient for proper function of wild-type POLγA. In addition, we find that this phenotype is overcome by increasing the dNTP concentration, e.g. dATP. At low dATP concentrations, the POLγA:Y955C enzyme stalls at dATP insertion sites and instead enters a polymerase/exonuclease idling mode. The POLγA:Y955C enzyme will compete with wild-type POLγA for primer utilization, and this will result in a heterogeneous population of short and long DNA replication products. In addition, there is a possibility that POLγA:Y955C is recruited to nicks of mtDNA and there enters an idling mode preventing ligation. Our results provide a novel explanation for the dominant mtDNA replication phenotypes seen in patients harboring the Y955C mutation, including the existence of site-specific stalling. Our data may also explain why mutations that disturb dATP pools can be especially deleterious for mtDNA synthesis.
  •  
25.
  •  
26.
  •  
27.
  • Bademci, Guney, et al. (författare)
  • FOXF2 is required for cochlear development in humans and mice.
  • 2019
  • Ingår i: Human molecular genetics. - : Oxford University Press (OUP). - 1460-2083 .- 0964-6906. ; 28:8, s. 1286-1297
  • Tidskriftsartikel (refereegranskat)abstract
    • Molecular mechanisms governing the development of the human cochlea remain largely unknown. Through genome sequencing, we identified a homozygous FOXF2 variant c.325A>T (p.I109F) in a child with profound sensorineural hearing loss associated with incomplete partition type I anomaly of the cochlea. This variant is not found in public databases or in over 1,000 ethnicity-matched control individuals. I109 is a highly conserved residue in the forkhead box (Fox) domain of FOXF2, a member of the Fox protein family of transcription factors that regulate the expression of genes involved in embryogenic development as well as adult life. Our in vitro studies show that the half-life of mutant FOXF2 is reduced compared to that of wildtype. Foxf2 is expressed in the cochlea of developing and adult mice. The mouse knockout of Foxf2 shows shortened and malformed cochleae, in addition to altered shape of hair cells with innervation and planar cell polarity defects. Expressions of Eya1 and Pax3, genes essential for cochlear development, are reduced in the cochleae of Foxf2 knockout mice. We conclude that FOXF2 plays a major role in cochlear development and its dysfunction leads to sensorineural hearing loss and developmental anomalies of the cochlea in humans and mice.
  •  
28.
  •  
29.
  • Baker, N L, et al. (författare)
  • Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy
  • 2005
  • Ingår i: Human Molecular Genetics. - : Oxford University Press (OUP). - 0964-6906 .- 1460-2083. ; 14:2, s. 279-293
  • Tidskriftsartikel (refereegranskat)abstract
    • Mutations in the three collagen VI genes COL6A1, COL6A2 and COL6A3 cause Bethlem myopathy and Ullrich congenital muscular dystrophy (UCMD). UCMD, a severe disorder characterized by congenital muscle weakness, proximal joint contractures and marked distal joint hyperextensibility, has been considered a recessive condition, and homozygous or compound heterozygous mutations have been defined in COL6A2 and COL6A3. In contrast, the milder disorder Bethlem myopathy shows clear dominant inheritance and is caused by heterozygous mutations in COL6A1, COL6A2 and COL6A3. This model, where dominant mutations cause mild Bethlem myopathy and recessive mutations cause severe UCMD was recently challenged when a patient with UCMD was shown to have a heterozygous in-frame deletion in COL6A1. We have studied five patients with a clinical diagnosis of UCMD. Three patients had heterozygous in-frame deletions in the N-terminal region of the triple helical domain, one in the alpha1(VI) chain, one in alpha2(VI) and one in alpha3(VI). Collagen VI protein biosynthesis and assembly studies showed that these mutations act in a dominant negative fashion and result in severe collagen VI matrix deficiencies. One patient had recessive amino acid changes in the C2 subdomain of alpha2(VI), which prevented collagen VI assembly. No collagen VI mutations were found in the fifth patient. These data demonstrate that rather than being a rare cause of UCMD, dominant mutations are common in UCMD, now accounting for four of the 14 published cases. Mutation detection in this disorder remains critical for accurate genetic counseling of patients and their families.
  •  
30.
  • Barekati, Zeinab, et al. (författare)
  • Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
  • 2010
  • Ingår i: Human Molecular Genetics. - : Oxford Journals. - 0964-6906 .- 1460-2083. ; 19:15, s. 2936-2946
  • Tidskriftsartikel (refereegranskat)abstract
    • The present study investigated promoter hypermethylation of TP53 regulatory pathways providing a potential link between epigenetic changes and mitochondrial DNA (mtDNA) alterations in breast cancer patients lacking a TP53 mutation. The possibility of using the cancer-specific alterations in serum samples as a blood-based test was also explored. Triple-matched samples (cancerous tissues, matched adjacent normal tissues and serum samples) from breast cancer patients were screened for TP53 mutations, and the promoter methylation profile of P14(ARF), MDM2, TP53 and PTEN genes was analyzed as well as mtDNA alterations, including D-loop mutations and mtDNA content. In the studied cohort, no mutation was found in TP53 (DNA-binding domain). Comparison of P14(ARF) and PTEN methylation patterns showed significant hypermethylation levels in tumor tissues (P < 0.05 and <0.01, respectively) whereas the TP53 tumor suppressor gene was not hypermethylated (P < 0.511). The proportion of PTEN methylation was significantly higher in serum than in the normal tissues and it has a significant correlation to tumor tissues (P < 0.05). mtDNA analysis revealed 36.36% somatic and 90.91% germline mutations in the D-loop region and also significant mtDNA depletion in tumor tissues (P < 0.01). In addition, the mtDNA content in matched serum was significantly lower than in the normal tissues (P < 0.05). These data can provide an insight into the management of a therapeutic approach based on the reversal of epigenetic silencing of the crucial genes involved in regulatory pathways of the tumor suppressor TP53. Additionally, release of significant aberrant methylated PTEN in matched serum samples might represent a promising biomarker for breast cancer.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 21-30 av 458
Typ av publikation
tidskriftsartikel (453)
forskningsöversikt (5)
Typ av innehåll
refereegranskat (454)
övrigt vetenskapligt/konstnärligt (4)
Författare/redaktör
Lindblom, A (18)
Hall, P (16)
Southey, MC (16)
Haiman, CA (16)
Giles, GG (15)
Hopper, JL (15)
visa fler...
Couch, FJ (14)
Henderson, BE (14)
Czene, K (13)
Dunning, AM (13)
Cox, A (13)
Chang-Claude, J (13)
Benitez, J. (12)
Groop, Leif (12)
Margolin, S (12)
Fasching, PA (12)
Bojesen, SE (12)
Le Marchand, L (12)
Dennis, J (11)
Andersen, Peter M. (11)
Milne, RL (11)
Andrulis, IL (11)
Beckmann, MW (11)
Peto, J (11)
Burwinkel, B (11)
aut (10)
Zheng, W. (10)
Brenner, H (10)
Riboli, Elio (10)
Nordestgaard, BG (10)
Olson, JE (10)
Severi, G (10)
Kere, J (9)
Peterlongo, P (9)
Melander, Olle (9)
Chanock, Stephen J (9)
Albanes, Demetrius (9)
Michailidou, K (9)
Brauch, H (9)
Hamann, U (9)
Schmidt, MK (9)
Broeks, A (9)
Ekici, AB (9)
Shen, CY (9)
Radice, P (9)
Mannermaa, A (9)
Kosma, VM (9)
Lambrechts, D (9)
Schumacher, F (9)
Devilee, P (9)
visa färre...
Lärosäte
Karolinska Institutet (233)
Lunds universitet (102)
Uppsala universitet (98)
Umeå universitet (56)
Göteborgs universitet (53)
Linköpings universitet (16)
visa fler...
Stockholms universitet (14)
Marie Cederschiöld högskola (6)
Örebro universitet (4)
Jönköping University (2)
Högskolan i Skövde (2)
Linnéuniversitetet (2)
Kungliga Tekniska Högskolan (1)
Högskolan i Halmstad (1)
Mittuniversitetet (1)
Gymnastik- och idrottshögskolan (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (458)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (224)
Naturvetenskap (39)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy